Analyst Rating Update on McKesson Corporation (MCK)

McKesson Corporation (NYSE:MCK) : Zacks Investment Research ranks McKesson Corporation (NYSE:MCK) as 3, which is a Hold recommendation. 7 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. 2 other analysts are mildly bullish on the stock and favor a Buy. A total of 5 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 14 research analysts is 1.82, which indicates as a Buy.

McKesson Corporation (NYSE:MCK) : Average target price received by McKesson Corporation (NYSE:MCK) is $194.46 with an expected standard deviation of $16.35. The most aggressive target on the stock is $220, whereas the most downbeat target is $172. 11 financial analysts are currently covering the stock.

For the current week, the company shares have a recommendation consensus of Buy. Also, Bank of America reinstates its view on McKesson Corporation (NYSE:MCK) according to the research report released by the firm to its investors. The shares have now been rated Neutral by the stock experts at the ratings house. The rating by the firm was issued on June 7, 2016.

McKesson Corporation (NYSE:MCK): stock turned positive on Tuesday. Though the stock opened at $174.37, the bulls momentum made the stock top out at $177.86 level for the day. The stock recorded a low of $174.37 and closed the trading day at $176.58, in the green by 2.29%. The total traded volume for the day was 1,609,590. The stock had closed at $172.63 in the previous days trading.

In an insider trading activity,The director officer (Chairman, President & CEO) of Mckesson Corp, Hammergren John H sold 37,420 shares at $182.87 on May 24, 2016. The Insider selling transaction had a total value worth of $6,842,995. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *